Trial Profile
GSC-100 in the treatment of subjects with relapsed or relapsed/refractory multiple myeloma
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 09 Feb 2006
Price :
$35
*
At a glance
- Drugs GCS 100 (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 09 Feb 2006 New trial record.